Smoking-related interstitial fibrosis (SRIF) is a common, histologically striking finding in smokers that must be distinguished from the idiopathic interstitial pneumonias and other chronic interstitial fibrosing lesions. It is characterised by marked thickening of alveolar septa by fibrosis composed of thick collagen bundles that have a distinctive hyalinised quality and often are admixed with variable numbers of hyperplastic smooth muscle fibres. There is minimal accompanying inflammation. This fibrosis is usually most prominent in subpleural and centrilobular parenchyma, but can be present elsewhere as well. It is accompanied by emphysema and respiratory bronchiolitis. Most patients are asymptomatic or only mildly symptomatic, and the clinical course is stable in most. This paper reviews the pathologic features of SRIF in detail, its differentiation from more ominous interstitial fibrosing processes, and the clinical implications of its diagnosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/jclinpath-2012-201338 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence.
Arch Bronconeumol
November 2024
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy. Electronic address:
In this narrative review, we address the ongoing challenges of lung cancer (LC) screening using chest low-dose computerized tomography (LDCT) and explore the contributions of artificial intelligence (AI), in overcoming them. We focus on evaluating the initial (baseline) LDCT examination, which provides a wealth of information relevant to the screening participant's health. This includes the detection of large-size prevalent LC and small-size malignant nodules that are typically diagnosed as LCs upon growth in subsequent annual LDCT scans.
View Article and Find Full Text PDFHypersensitivity pneumonitis radiologic features in interstitial lung diseases.
Respir Med
January 2025
Center of Excellence for Interstitial Lung Diseases, Tel Aviv Medical Center, Tel Aviv University, Israel; Institute of Pulmonary Medicine, Tel Aviv Medical Center, Tel Aviv University, Israel. Electronic address:
Background: The radiologic criteria of hypersensitivity pneumonitis (HP) guidelines focus on four HP compatible features (HPCF) in high-resolution computed tomography (HRCT): ground glass opacities, mosaic attenuation, air-trapping, and centrilobular nodules. However, evidence to support these criteria are limited.
Methods: Consecutive interstitial lung disease (ILD) patients who underwent HRCT between 2016 and 2021 in three medical centers were included.
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy.
J Dermatolog Treat
December 2024
Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Article Synopsis
- * A case study of a 69-year-old man highlighted respiratory issues after 18 months of treatment, revealing significant lung damage through medical imaging and biopsy, which pointed to immune cell involvement.
- * The findings emphasize the need for close lung monitoring in patients on biologic therapies, especially those with existing lung problems, as ixekizumab may lead to serious inflammatory responses.
Paraseptal Lucencies Mimicking Emphysema in a Non-smoker With Acute Lung Injury in COVID-19.
Cureus
October 2024
Cardiothoracic Imaging, University of Texas Southwestern Medical Center, Dallas, USA.
Paraseptal emphysema can be smoking-related but has other causes, including surfactant deficiency, COVID-19, and age. The typical acute chest tomographic findings of COVID-19 include bilateral ground-glass opacities with or without consolidation and interstitial thickening in a peripheral and posterior predominant distribution. Evolution of these findings can occur and ultimately lead to fibrosis.
View Article and Find Full Text PDFSmoking-related interstitial lung disease: A narrative review.
Chron Respir Dis
October 2024
Department of Pneumology, Santiago de Compostela University Hospital Complex, Santiago de Compostela, Spain.
Although smoking-related interstitial lung diseases (SR-ILD) are a relatively rare group of entities, they are a relevant public health problem of growing importance, both because they affect young adults and because of their increasing prevalence in recent years due to increased tobacco consumption. In patients who smoke and have non-specific respiratory symptoms, SR-ILD should be ruled out, a term that encompasses a group of different entities in which the basis for diagnosis is the smoking history together with compatible respiratory functional findings, radiology and/or histology. An association has been established between tobacco smoke and a group of diseases that include respiratory bronchiolitis-associated interstitial lung disease (2%-3% of all ILD), desquamative interstitial pneumonia (<1%), Langerhans cell histiocytosis (3%-5%) and acute eosinophilic pneumonia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!